Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?
Main Author: | |
---|---|
Publication Date: | 2021 |
Other Authors: | , , , |
Format: | Article |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | http://hdl.handle.net/10400.21/12825 |
Summary: | Tea has been consumed for thousands of years. Despite the different varieties, particular emphasis has been placed on green tea (GT), considering the associated health benefits following its regular consumption, some of which are due to its polyphenol constituents, such as epigallocatechin-3-gallate (EGCG). Tea is not prone to the growth of microorganisms, except fungus, when proper storage, handling, and packing conditions are compromised. Consequently, mycotoxins, secondary metabolites of fungi, could contaminate tea samples, affecting human health. In the present study, we aimed to assess the balance between risks (due to mycotoxins and high levels of EGCG) and benefits (due to moderate intake of EGCG) associated with the consumption of GT. For this, 20 GT samples (10 in bulk and 10 in bags) available in different markets in Lisbon were analyzed through a LC-MS/MS method, evaluating 38 different mycotoxins. Six samples revealed detectable values of the considered toxins. Current levels of mycotoxins and EGCG intake were not associated with health concerns. Scenarios considering an increasing consumption of GT in Portugal showed that drinking up to seven cups of GT per day should maximize the associated health benefits. The present study contributes to the future establishment of GT consumption recommendations in Portugal. |
id |
RCAP_ed78f0c58289cc948b27dbd790893b2b |
---|---|
oai_identifier_str |
oai:repositorio.ipl.pt:10400.21/12825 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits?Green teaMycotoxinPolyphenolsRisk-benefit assessmentEpigallocatechin-3-gallateEGCGIPL/2020/TEAResMyc_ESTeSLUIDB/05608/2020UIDP/05608/2020Tea has been consumed for thousands of years. Despite the different varieties, particular emphasis has been placed on green tea (GT), considering the associated health benefits following its regular consumption, some of which are due to its polyphenol constituents, such as epigallocatechin-3-gallate (EGCG). Tea is not prone to the growth of microorganisms, except fungus, when proper storage, handling, and packing conditions are compromised. Consequently, mycotoxins, secondary metabolites of fungi, could contaminate tea samples, affecting human health. In the present study, we aimed to assess the balance between risks (due to mycotoxins and high levels of EGCG) and benefits (due to moderate intake of EGCG) associated with the consumption of GT. For this, 20 GT samples (10 in bulk and 10 in bags) available in different markets in Lisbon were analyzed through a LC-MS/MS method, evaluating 38 different mycotoxins. Six samples revealed detectable values of the considered toxins. Current levels of mycotoxins and EGCG intake were not associated with health concerns. Scenarios considering an increasing consumption of GT in Portugal showed that drinking up to seven cups of GT per day should maximize the associated health benefits. The present study contributes to the future establishment of GT consumption recommendations in Portugal.MDPIRCIPLAssunção, RicardoTwarużek, MagdalenaKosicki, RobertViegas, CarlaViegas, Susana2021-02-11T17:34:18Z2021-022021-02-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.21/12825eng10.3390/toxins13020119info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-12T07:37:36Zoai:repositorio.ipl.pt:10400.21/12825Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:50:42.614895Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? |
title |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? |
spellingShingle |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? Assunção, Ricardo Green tea Mycotoxin Polyphenols Risk-benefit assessment Epigallocatechin-3-gallate EGCG IPL/2020/TEAResMyc_ESTeSL UIDB/05608/2020 UIDP/05608/2020 |
title_short |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? |
title_full |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? |
title_fullStr |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? |
title_full_unstemmed |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? |
title_sort |
Drinking green tea: despite the risks due to mycotoxins, is it possible to increase the associated health benefits? |
author |
Assunção, Ricardo |
author_facet |
Assunção, Ricardo Twarużek, Magdalena Kosicki, Robert Viegas, Carla Viegas, Susana |
author_role |
author |
author2 |
Twarużek, Magdalena Kosicki, Robert Viegas, Carla Viegas, Susana |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
RCIPL |
dc.contributor.author.fl_str_mv |
Assunção, Ricardo Twarużek, Magdalena Kosicki, Robert Viegas, Carla Viegas, Susana |
dc.subject.por.fl_str_mv |
Green tea Mycotoxin Polyphenols Risk-benefit assessment Epigallocatechin-3-gallate EGCG IPL/2020/TEAResMyc_ESTeSL UIDB/05608/2020 UIDP/05608/2020 |
topic |
Green tea Mycotoxin Polyphenols Risk-benefit assessment Epigallocatechin-3-gallate EGCG IPL/2020/TEAResMyc_ESTeSL UIDB/05608/2020 UIDP/05608/2020 |
description |
Tea has been consumed for thousands of years. Despite the different varieties, particular emphasis has been placed on green tea (GT), considering the associated health benefits following its regular consumption, some of which are due to its polyphenol constituents, such as epigallocatechin-3-gallate (EGCG). Tea is not prone to the growth of microorganisms, except fungus, when proper storage, handling, and packing conditions are compromised. Consequently, mycotoxins, secondary metabolites of fungi, could contaminate tea samples, affecting human health. In the present study, we aimed to assess the balance between risks (due to mycotoxins and high levels of EGCG) and benefits (due to moderate intake of EGCG) associated with the consumption of GT. For this, 20 GT samples (10 in bulk and 10 in bags) available in different markets in Lisbon were analyzed through a LC-MS/MS method, evaluating 38 different mycotoxins. Six samples revealed detectable values of the considered toxins. Current levels of mycotoxins and EGCG intake were not associated with health concerns. Scenarios considering an increasing consumption of GT in Portugal showed that drinking up to seven cups of GT per day should maximize the associated health benefits. The present study contributes to the future establishment of GT consumption recommendations in Portugal. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02-11T17:34:18Z 2021-02 2021-02-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.21/12825 |
url |
http://hdl.handle.net/10400.21/12825 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.3390/toxins13020119 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833598355608961024 |